Assoc. Prof. Dr. Marta Slavkova, Medical University of Sofia, Bulgaria
Assoc. Prof. Dr. Marta Slavkova is an esteemed pharmaceutical researcher specializing in Pharmaceutical Technology and Biopharmacy. With a Ph.D. and ongoing specialization in Toxicology and Toxicological Analysis, she has made significant contributions to nanoparticulate drug delivery systems. Her research focuses on improving chemotherapeutics’ efficacy while reducing off-target effects. She has been a DAAD scholar in DĂĽsseldorf, Germany, and has actively participated in international conferences. As a reviewer for WOS-indexed journals, she plays a crucial role in scientific advancements. Fluent in English and German, she teaches master’s students in Pharmaceutical Technology and continues to explore innovative drug delivery systems.
🌍 Professional Profile:
Google Scholar
Orcid
Scopus
🏆 Suitability for Best Researcher Award
Dr. Slavkova’s research in Medical and Pharmaceutical Technology, particularly in nanoparticulate drug delivery systems, showcases groundbreaking advancements in drug targeting and biopharmaceutical characterization. Her expertise in developing novel nanocarriers, including mesoporous silica and lipid-based nanoparticles, enhances therapeutic efficacy and safety. Her international collaborations, DAAD research scholarship, and extensive publication record make her a distinguished candidate for the Best Researcher Award. With hands-on experience in ISO quality standards, manuscript reviewing for WOS-indexed journals, and active participation in global conferences, Dr. Slavkova is an influential researcher dedicated to the progress of pharmaceutical sciences.
🎓 EducationÂ
Dr. Slavkova earned her Ph.D. in Pharmaceutical Technology with a specialization in Biopharmacy. She is currently advancing her expertise in Toxicology and Toxicological Analysis. Her academic achievements include a DAAD scholarship for a 10-month research grant in DĂĽsseldorf, Germany (2014-2015). Additionally, she has completed an auditor course in ISO 9001:2015 and ISO 19011:2018, equipping her with quality management expertise. Her extensive education and professional training allow her to bridge scientific research with industry standards. Fluent in English and German, she integrates international knowledge into her research and teaching, further strengthening her academic and professional profile.
👨‍🏫 Experience
Dr. Slavkova is an experienced researcher and academic, currently engaged in nanoparticulate drug delivery systems. She teaches Pharmaceutical Technology to master’s students and contributes significantly to pharmaceutical research. Her work includes developing novel drug carriers for parenteral, dermal, and oral applications, particularly for chemotherapeutics and natural bioactive compounds. She has participated in multiple international conferences, presenting her findings on improving drug efficacy and minimizing side effects. As a reviewer for WOS-indexed journals, she evaluates cutting-edge research, ensuring the highest quality standards. Her background in ISO auditing adds another layer of expertise to her scientific and professional endeavors.
🏅 Awards and HonorsÂ
Dr. Slavkova has received numerous accolades for her contributions to pharmaceutical research. She was awarded a prestigious DAAD scholarship for a research grant in DĂĽsseldorf, Germany (2014-2015). She has been an invited speaker at various international conferences, showcasing her expertise in nanoparticle drug delivery systems. Her active role as a reviewer for high-impact WOS-indexed journals highlights her influence in the scientific community. Additionally, she has been recognized for her contributions to pharmaceutical education, mentoring master’s students in advanced pharmaceutical technologies. Her interdisciplinary approach to drug delivery research has earned her recognition from both academic and industry professionals.
🔬 Research FocusÂ
Dr. Slavkova’s research revolves around nanoparticulate drug delivery systems, targeting various administration routes such as parenteral, dermal, and oral. She specializes in mesoporous silica nanoparticles, polymer nanoparticles, lipid nanocarriers, and hybrid nanoparticle systems. Her work aims to enhance chemotherapeutic efficacy while reducing systemic toxicity. Additionally, she investigates the biomedical potential of natural compounds like curcumin, quercetin, and berberine. Her expertise in biopharmaceutical characterization allows her to develop innovative drug targeting methods. With a strong focus on medical and pharmaceutical technology, her research contributes to the advancement of precision medicine and targeted therapies.
đź“–Â Publication Top Notes
-
Orodispersible Drug Formulations for Children and Elderly
- Year: 2015
- Citations: 268
-
Gel Formulations for Topical Treatment of Skin Cancer: A Review
-
Superior Proapoptotic Activity of Curcumin-Loaded Mixed Block Copolymer Micelles with Mitochondrial Targeting Properties
-
A Novel Approach for Fabricating Nanocomposite Materials by Embedding Stabilized Core-Shell Micelles into Polysaccharide Cryogel Matrix
-
10 Years EU Regulation of Pediatric Medicines–Impact on Cardiovascular Drug Formulations